Jérémie Guedj
About
Jérémie Guedj is a scholar working on Epidemiology, Infectious Diseases and Hepatology.
According to data from OpenAlex, Jérémie Guedj has authored 109 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 45 papers in Infectious Diseases and 42 papers in Hepatology. Recurrent topics in Jérémie Guedj's work include Hepatitis C virus research (40 papers), Hepatitis B Virus Studies (32 papers) and Liver Disease Diagnosis and Treatment (23 papers). Jérémie Guedj is often cited by papers focused on Hepatitis C virus research (40 papers), Hepatitis B Virus Studies (32 papers) and Liver Disease Diagnosis and Treatment (23 papers). Jérémie Guedj collaborates with scholars based in France, United States and Switzerland. Jérémie Guedj's co-authors include Alan S. Perelson, France Mentré, Harel Dahari, Xavier de Lamballerie, Vincent Madelain, Libin Rong, Daniel Commenges, Thi Huyen Tram Nguyen, Rodolphe Thiébaut and Thomas J. Layden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.
In The Last Decade
Jérémie Guedj
108 papers receiving 3.0k citations
Peers
Jérémie Guedj
Fabio Luciani Australia
Sayed F. Abdelwahab Egypt
Ioana Bica United States
Harel Dahari United States
W. Katherine Yih United States
Thomas J. Layden United States
Nancy P. Lam United States
Samer S. El‐Kamary United States
John J. Aponte Spain
Sherif A. El‐Kafrawy Saudi Arabia
Citations per year, relative to Jérémie Guedj Jérémie Guedj (= 1×)
peers
Fabio Luciani
Countries citing papers authored by Jérémie Guedj
Since
Specialization
Citations
This map shows the geographic impact of Jérémie Guedj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérémie Guedj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérémie Guedj more than expected).
Fields of papers citing papers by Jérémie Guedj
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jérémie Guedj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérémie Guedj. The network helps show where Jérémie Guedj may publish in the future.
Co-authorship network of co-authors of Jérémie Guedj
This figure shows the co-authorship network connecting the top 25 collaborators of Jérémie Guedj. A scholar is included among the top collaborators of Jérémie Guedj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérémie Guedj. Jérémie Guedj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Marchand, Mathilde, António Gonçalves, François Mercier, et al.. (2024). Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two‐stage approaches. CPT Pharmacometrics & Systems Pharmacology. 13(6). 1017–1028.
2.
Brichler, Ségolène, Claire Fougerou‐Leurent, Emmanuel Gordien, et al.. (2024). Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide. JHEP Reports. 6(8). 101070–101070.
3.
Gaymard, Alexandre, Clément Massonnaud, Nathan Peiffer‐Smadja, et al.. (2024). Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial. Journal of Antimicrobial Chemotherapy. 79(11). 2887–2895.
4.
Lingas, Guillaume, Cédric Laouenan, Sarah Tubiana, et al.. (2023). High sera levels of SARS‐CoV‐2 N antigen are associated with death in hospitalized COVID‐19 patients. Journal of Medical Virology. 95(11). e29247–e29247.
5.
Bruno, René, Pascal Chanu, Matts Kågedal, et al.. (2023). Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models. British Journal of Cancer. 129(9). 1383–1388.
6.
Gonçalves, António, Mathilde Marchand, Phyllis Chan, et al.. (2023). Comparison of two‐stage and joint TGI‐OS modeling using data from six atezolizumab clinical studies in patients with metastatic non‐small cell lung cancer. CPT Pharmacometrics & Systems Pharmacology. 13(1). 68–78.
7.
Lingas, Guillaume, Nadège Néant, Alexandre Gaymard, et al.. (2022). Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. Journal of Antimicrobial Chemotherapy. 77(5). 1404–1412.
8.
Reynard, Stéphanie, Vincent Madelain, Jérémie Guedj, et al.. (2021). Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates. PLoS neglected tropical diseases. 15(3). e0009300–e0009300.
9.
Débarre, Florence, António Gonçalves, Olivier Tenaillon, et al.. (2021). Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action. PLoS Computational Biology. 17(3). e1008752–e1008752.
10.
Eloy, Philippine, Roger Le Grand, Denis Malvy, & Jérémie Guedj. (2021). Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?. EBioMedicine. 74. 103663–103663.
11.
Bruno, René, Dean Bottino, Dinesh P. de Alwis, et al.. (2019). Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic Models. Clinical Cancer Research. 26(8). 1787–1795.
12.
Tardivon, Coralie, René Bruno, Benjamin Wu, et al.. (2019). Association Between Tumor Size Kinetics and Survival in Patients With Urothelial Carcinoma Treated With Atezolizumab: Implication for Patient Follow‐Up. Clinical Pharmacology & Therapeutics. 106(4). 810–820.
13.
Kutala, B., Jérémie Guedj, Tarik Asselah, et al.. (2014). Impact of Treatment against Hepatitis C Virus on Overall Survival of Naive Patients with Advanced Liver Disease. Antimicrobial Agents and Chemotherapy. 59(2). 803–810.
14.
Laouenan, Cédric, Patrick Marcellin, Martine Lapalus, et al.. (2014). Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon during Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients. Antimicrobial Agents and Chemotherapy. 58(9). 5332–5341.
15.
Laouenan, Cédric, Jérémie Guedj, Gilles Peytavin, et al.. (2014). A Model‐Based Illustrative Exploratory Approach to Optimize the Dosing of Peg‐IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy. CPT Pharmacometrics & Systems Pharmacology. 4(1). 37–40.
16.
Guedj, Jérémie, et al.. (2013). 1196 ANALYSIS OF THE KINETICS OF VIRAL DECLINE DURING 14 DAYS OF ADMINISTRATION OF SOFOSBUVIR AND GS-0938. Journal of Hepatology. 58. S486–S487.
17.
Rong, Libin, Jérémie Guedj, Harel Dahari, et al.. (2013). Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model. PLoS Computational Biology. 9(3). e1002959–e1002959.
18.
Prague, Mélanie, Daniel Commenges, Jérémie Guedj, Julia Drylewicz, & Rodolphe Thiébaut. (2013). NIMROD: A program for inference via a normal approximation of the posterior in models with random effects based on ordinary differential equations. Computer Methods and Programs in Biomedicine. 111(2). 447–458.
19.
Guedj, Jérémie & Avidan U. Neumann. (2010). Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics. Journal of Theoretical Biology. 267(3). 330–340.
20.
Guedj, Jérémie, Rodolphe Thiébaut, & Daniel Commenges. (2007). Practical Identifiability of HIV Dynamics Models. Bulletin of Mathematical Biology. 69(8). 2493–2513.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Fabio Luciani Breakdown of academic impact, for papers by Sayed F. Abdelwahab Breakdown of academic impact, for papers by Ioana Bica Breakdown of academic impact, for papers by Harel Dahari Breakdown of academic impact, for papers by W. Katherine Yih Breakdown of academic impact, for papers by Thomas J. Layden Breakdown of academic impact, for papers by Nancy P. Lam Breakdown of academic impact, for papers by Samer S. El‐Kamary Breakdown of academic impact, for papers by John J. Aponte Breakdown of academic impact, for papers by Sherif A. El‐Kafrawy